1. Home
  2. SPRY vs UCTT Comparison

SPRY vs UCTT Comparison

Compare SPRY & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • UCTT
  • Stock Information
  • Founded
  • SPRY 2015
  • UCTT 1991
  • Country
  • SPRY United States
  • UCTT United States
  • Employees
  • SPRY N/A
  • UCTT N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • UCTT Semiconductors
  • Sector
  • SPRY Health Care
  • UCTT Technology
  • Exchange
  • SPRY Nasdaq
  • UCTT Nasdaq
  • Market Cap
  • SPRY 1.1B
  • UCTT 1.2B
  • IPO Year
  • SPRY N/A
  • UCTT 2004
  • Fundamental
  • Price
  • SPRY $8.96
  • UCTT $27.41
  • Analyst Decision
  • SPRY Strong Buy
  • UCTT Strong Buy
  • Analyst Count
  • SPRY 4
  • UCTT 2
  • Target Price
  • SPRY $31.25
  • UCTT $32.50
  • AVG Volume (30 Days)
  • SPRY 1.8M
  • UCTT 476.8K
  • Earning Date
  • SPRY 11-11-2025
  • UCTT 10-28-2025
  • Dividend Yield
  • SPRY N/A
  • UCTT N/A
  • EPS Growth
  • SPRY N/A
  • UCTT N/A
  • EPS
  • SPRY N/A
  • UCTT N/A
  • Revenue
  • SPRY $112,339,000.00
  • UCTT $2,110,600,000.00
  • Revenue This Year
  • SPRY N/A
  • UCTT N/A
  • Revenue Next Year
  • SPRY $193.13
  • UCTT $4.45
  • P/E Ratio
  • SPRY N/A
  • UCTT N/A
  • Revenue Growth
  • SPRY 22367.80
  • UCTT 6.65
  • 52 Week Low
  • SPRY $8.45
  • UCTT $16.66
  • 52 Week High
  • SPRY $18.90
  • UCTT $40.64
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 36.31
  • UCTT 46.67
  • Support Level
  • SPRY $9.08
  • UCTT $26.75
  • Resistance Level
  • SPRY $10.38
  • UCTT $31.11
  • Average True Range (ATR)
  • SPRY 0.51
  • UCTT 1.53
  • MACD
  • SPRY -0.09
  • UCTT -0.29
  • Stochastic Oscillator
  • SPRY 17.43
  • UCTT 15.91

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.

Share on Social Networks: